ProCE Banner Activity

Safety and Immunogenicity of BNT162b2 COVID-19 Vaccine Among Adults With AIIRD vs the General Population in Israel

Slideset Download
Conference Coverage
Most DMARDs, including methotrexate, biologics, and JAK inhibitors, can be continued when the BNT162b2 mRNA COVID-19 vaccine is given.

Released: July 30, 2021

Expiration: July 29, 2022

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Janssen administered by Scientific Affairs